Brought to you by 
PowderMed spins off of Chiron; raises £20mm
12 Nov 2020
Executive Summary
PowderMed Ltd., a newly formed company focused on developing therapeutic DNA vaccines, has spun off from Chiron Vaccines and raised £20mm ($35.2mm).
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Vaccines
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com